Robert E. Waltermire Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 months, 1 week ago
Robert E. Waltermire has an estimated net worth of at least $10.9 million*, as of Oct. 29, 2025. They own 35,000 shares of MDGL stock. They have sold 28,621 shares of MDGL stock since 2021, for an estimated $8.5 million.
Robert E. Waltermire $MDGL SEC Form 4 Insider Trading
Robert E. Waltermire has filed a total of 24 insider trades in $MDGL since 2021. Their most recent trade was a sale of 4,701 shares, made on Mar 05, 2025. Their largest trade was a sale of 4,701 shares, made on Mar 05, 2025. We estimate that they now own 35,000 shares of $MDGL, worth an estimated $2.4 million.
Insider Trading at $MDGL
There have been a total of 650 insider trades reported at $MDGL since 2021, with 590,368 shares purchased and 876,162 shares sold. The most active insider traders in $MDGL stock have been Brian Joseph Lynch, Mardi Dier, and Rebecca Taub. The most recent trade was a sale of 40 shares reported by Mardi Dier (EVP and CFO), made on Mar 06, 2026.
History of Insider Stock Trades by Robert E. Waltermire
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
MDGL
|
Sale | 4,701 | Mar 05, 2025 | March 7, 2025, 6:40 p.m. |
|
MDGL
|
Sale | 1,043 | Mar 05, 2025 | March 7, 2025, 6:40 p.m. |
|
MDGL
|
Sale | 1,077 | Mar 05, 2025 | March 7, 2025, 6:40 p.m. |
|
MDGL
|
Sale | 1,412 | Mar 05, 2025 | March 7, 2025, 6:40 p.m. |
|
MDGL
|
Sale | 900 | Mar 05, 2025 | March 7, 2025, 6:40 p.m. |
|
MDGL
|
Sale | 1,777 | Mar 05, 2025 | March 7, 2025, 6:40 p.m. |
|
MDGL
|
Sale | 1,146 | Mar 05, 2025 | March 7, 2025, 6:40 p.m. |
|
MDGL
|
Sale | 400 | Mar 05, 2025 | March 7, 2025, 6:40 p.m. |
|
MDGL
|
Sale | 1,657 | Mar 05, 2025 | March 7, 2025, 6:40 p.m. |
|
MDGL
|
Sale | 1,052 | Feb 28, 2025 | March 4, 2025, 10:24 p.m. |
|
MDGL
|
Sale | 175 | Feb 28, 2025 | March 4, 2025, 10:24 p.m. |
|
MDGL
|
Sale | 103 | Jan 24, 2025 | Jan. 27, 2025, 6:03 p.m. |
|
MDGL
|
Sale | 442 | Jan 17, 2025 | Jan. 17, 2025, 8:08 p.m. |
|
MDGL
|
Sale | 1,900 | Jun 14, 2024 | June 18, 2024, 9:39 p.m. |
|
MDGL
|
Sale | 2,000 | Jun 12, 2024 | June 14, 2024, 9:44 p.m. |
|
MDGL
|
Sale | 1,036 | May 21, 2024 | May 23, 2024, 9:36 p.m. |
|
MDGL
|
Sale | 1,000 | Dec 14, 2023 | Dec. 18, 2023, 5:30 p.m. |
|
MDGL
|
Sale | 1,000 | Dec 14, 2023 | Dec. 18, 2023, 5:30 p.m. |
|
MDGL
|
Sale | 1,000 | Dec 15, 2023 | Dec. 18, 2023, 5:30 p.m. |
|
MDGL
|
Sale | 1,000 | Dec 15, 2023 | Dec. 18, 2023, 5:30 p.m. |
|
MDGL
|
Sale | 800 | Dec 12, 2023 | Dec. 14, 2023, 5:30 p.m. |
|
MDGL
|
Sale | 1,000 | Dec 13, 2023 | Dec. 14, 2023, 5:30 p.m. |
|
MDGL
|
Sale | 500 | Dec 12, 2023 | Dec. 14, 2023, 5:30 p.m. |
|
MDGL
|
Sale | 1,500 | Dec 13, 2023 | Dec. 14, 2023, 5:30 p.m. |
$MDGL Executives and Stock Owners with Insider Trades
-
Brian Joseph Lynch, SVP and General Counsel
-
Mardi Dier, EVP and CFO
-
Rebecca Taub, Pres., R&D, and CMO
-
Carole Huntsman, Chief Commercial Officer
-
Robert E. Waltermire, Senior VP, Chief Pharma Dev.
-
Remy Sukhija, Chief Commercial Officer
-
Shannon T Kelley, General Counsel
-
William John Sibold, President and CEO
-
Mardi Dier, SVP and CFO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.